Saito 2010.

Trial name or title	JCOG0505
Methods	Phase III RCT
Participants	Women with IVB persistent or recurrent cervical cancer not amenable to curative treatment with local therapy
Interventions	Arm 1: paclitaxel 135 mg/m2 over 24 h d1 plus carboplatin AUC 5 d1 q21 Arm 2: paclitaxel 135 mg/m2 over 24 h d1 plus cisplatin 50 mg/m2 2 h d2 q21
Outcomes	OS PFS Toxicity Unplanned hospital admissions (surrogate for QoL)
Starting date	21 February 2006
Contact information	kitagawa.ryo@east.ntt.co.jp
Notes	Planned sample size 250

AUC: area under curve; d: day; h: hour; OS: overall survival; PFS: progression‐free survival; QoL: quality of life; RCT: randomised controlled trial.